Heart Failure Drugs Flashcards
Digoxin
Use: HF and AFib
MOA: inhibits Na/K ATPase, secondarily increases intracellular Ca via Na/Ca exchanger
Effect: positive inotropic, negative chronotropic and dromotropic
Dobutamine
Use: Acute treatment of severe HF
MOA: B1-agonist
Effect: positive inotropic
Pimobenden
Use: HF (DCM & mitral valve insufficiency)
MOA: PDE3 & PDE5 inhibitor in heart and blood vessels
Effect: positive inotropic, vasodilator
Metoprolol
Use: HCM
MOA: slows HR, relaxes ventricular wall so that diastolic filling improves
Effect: beta blocker; decreased HR, but improved CO
Enalapril & Benazepril & Imidipril
Use: HF and Hypertension
MOA: inhibits angiotensin converting enzyme (ACE)
Effect: reduced Angiotensin II levels = vasodilation (mostly arteriolar) and reducing aldosterone release
Valsartan & Telmisartan
Use: AT1 receptor antagonist
MOA: inhibits actions of angiotensin II
Effects: vasodilation (mostly arteriolar) and reduces aldosterone release
Nitroglycerin & nitroprusside
Use: HF
MOA: exogenous sources of nitric oxide
Effect: venodilation and reduced preload
Prazosin
Use: HF and Hypertension
MOA: A1 adrenergic receptor antagonist
Effect: arteriolar dilation and reduced afterload
Hydralazine
Use: HF and Hypertension
MOA: unclear, may involve decrease vascular smooth muscle calcium
Effects: arteriolar and venous dilation (reduced preload and afterload)
Sildenafil
Use: Pulmonary and hypertension
MOA: PDE5 inhibitor, preventing cGMP breakdown
Effect: vasodilation in lung and penile circulation, reduced pressure